Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 59 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
581 16.4 months Hormone-refractory prostate cancer 4 Chemotherapy
Hormone
University of Michigan School of Medicine United States 10/2003
Treatment Details: Patients: This Phase II trial involved 37 patients with hormone refractory (androgen independent) prostate cancer. Median age was 66 years and median PSA was 63 (range 1.1 2021). Treat
 
582 16.4 months Metastatic breast cancer 5 Chemotherapy
University of Pittsburgh United States 11/2011
Treatment Details: Patients: This phase II study involved women with previously treated but recurrent or metastatic breast cancer who were divided into two separate treatment groups. Group A included 225 pat
 
583 16.4 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
Austin Health Australia 7/2010
Treatment Details: Patients: This study involved patients with metastatic colorectal cancer who were divided into 3 separate treatment groups. Group A consisted of 156 patients with a median age of 69 years
 
584 16.4 months Recurrent epithelial ovarian cancer 4 Chemotherapy
Irving Cancer Center United States 12/2008
Treatment Details: Patients: This phase 2 study involved 40 women with recurrent primary peritoneal or epithelial ovarian cancer. The median age was 58, ranging from 30 to 82 years of age. Treatment: Pati
 
585 16.4 months NSCLC 5 Chemotherapy
Radiation
Yokohama Municipal Citizen's Hospital Japan 12/2009
Treatment Details: Patients: This phase II study involved 26 patients with unresectable stage III non-small cell lung cancer. Of these, 84.6% were male and the median age was 63 years. Treatment: Patient
 
586 16.4 months colorectal (metastatic) 4 Chemotherapy
M. D. Anderson Cancer Center United States 5/2006
Treatment Details: Patients: This Phase II trial involved a total of 55 patients with metastatic colorectal cancer. There were 34 men and 21 women. The median age was 51. Forty-eight patients had prior surg
 
587 16.4 months Transitional cell carcinoma of the urothelial tract 5 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 9/2009
Treatment Details: Patients: This study involved 60 patients with advanced transitional cell carcinoma of the urothelium. The median patient age was 62 years and 46 were male. Treatment: Patients were tr
 
588 16.4 months Advanced Colorectal Cancer 4 Immunotherapy
Cancer Vaccine Center, Kurume University Japan 10/2014
Treatment Details: Patients: This phase 2 study involved 60 previously treated advanced colorectal cancer patients. The median patient age was 60 years and 33 were male. Treatment: Patients received immu
 
589 16.3 months GBM 5 Biologic therapy
Chemotherapy
Radiation
University of Colorado School of Medicine United States 12/2014
Treatment Details: Patients: This phase 2 study involved 30 glioblastoma patients who were newly diagnosed. The median patient age was 57 years and 17 were male. Treatment: Patients received radiation th
 
590 16.3 months GBM 5 Chemotherapy
Radiation
UAB Department of Neurology United States 5/2015
Treatment Details: Patients: This phase 2 study involved unmethylated MGMT gene promoter glioblastoma patients who were divided into two separate treatment groups. Group A had 88 patients with a median age of
 
Page 59 of 187  | Previous Page  | Next Page